ALBEMARLE CORPORATION

Lobbying for ALBEMARLE CORPORATION · Specialty Chemical manufacturer

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Expenses

$630,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 4016
Department of Defense Appropriations Act, 2026

Lobbying activity 6

Taxation/Internal Revenue Code

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

Foreign Relations

Issues related to trade and mineral supply

Manufacturing

Public Law 117-169, Inflation Reduction Act of 2022, issues related to implementation, tax credits and foreign entity of concern

Defense

H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law No: 119-4); H.R.4016, Department of Defense Appropriations Act, 2026; issues related to lithium batteries

Natural Resources

Issues related to critical minerals development and oil field brine lithium development (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

Trade (domestic/foreign)

Issues related to mineral supply (Andrew Sady-Kennedy engaged in lobbying only at US House and US Senate)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.